Wednesday, December 13, 2006

 

FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression



PR Newswire - SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder -- WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced
Source: sev.prnewswire.com

Garden State Business Briefs
Bridgeton News - Treating acute bipolar disorder with a single medication may help patients adhere to their medication regimen," said John Patterson condi tion that strikes people in their teens and late 20s and causes episodes of mania and depression.
Source: www.nj.com

Doctors offer their insights
Philadelphia Daily News - Speculation circulated that perhaps he suffers from bipolar disorder, which is Or whether, as he said, he simply suffered a bad reaction to mixing pain medication Depression has not appeared to be an issue with Owens. And yet, as Nathanson and
Source: www.philly.com


Click here for more information about psychotic depression psychotic depression





<< Home

This page is powered by Blogger. Isn't yours?